Patent · US Active

Substituted quinazolin-4-one compounds for antagonizing TRPV3 function

US7893260B2 · kind B2 · utility

21Cited by

15References

13Claims

0Family size

Assignee

Hydra Biosciences, LLC · US

Inventors

Jayhong A. Chong · Brookline, US
Christopher Fanger · Bolton, US
Glenn R. Larsen · Sudbury, US
William C. Lumma, Jr. · Pennsburg, US
Magdalene M. Moran · Brookline, US
Amy Ripka · Reading, US
Dennis John Underwood · Brookline, US
Manfred Weigele · North Caldwell, US
Xiaoguang Zhen · New York, US

Key dates

Filing date	Nov 3, 2006
Grant date	Feb 22, 2011
Priority date	—
Expiry date	Jan 1, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. Suitable compounds include but are not limited to, for example, substituted quinazolin-4-ones of formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.